Clinical Trial Update: A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

View source ↗

Summary

This is a multicenter, prospective real-world study evaluating iparomlimab and tuvonralimab (QL1706) for locally advanced or metastatic solid tumors; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: PENG YUAN | Conditions: Solid Tumor Cancer, Metastatic Solid Tumors | Status: NOT_YET_RECRUITING